Rigel Pharmaceuticals, Inc. (RIGL)
30.72
+0.25
(+0.82%)
USD |
NASDAQ |
Apr 23, 16:00
30.72
0.00 (0.00%)
After-Hours: 06:11
Rigel Pharmaceuticals Market Cap : 567.49M for April 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 819.79B |
| BioMarin Pharmaceutical, Inc. | 10.38B |
| Amicus Therapeutics, Inc. | 4.540B |
| Nektar Therapeutics | 1.579B |
| Madrigal Pharmaceuticals, Inc. | 11.90B |
Market Cap Related Metrics
| PE Ratio | 1.624 |
| PS Ratio | 1.965 |
| PEG Ratio | 0.0009 |
| Price to Book Value | 1.450 |
| Price to Free Cash Flow | 7.642 |
| Price | 30.72 |
| Earnings Yield | 61.56% |
| PEGY Ratio | 0.0009 |
| Operating PE Ratio | 4.608 |
| Normalized PE Ratio | 1.624 |